Related Experiment Video
Updated: Sep 16, 2025
09:54
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
5.8K
CLINICALLY RELEVANT METALLIC NANOPARTICLES IN TUBERCULOSIS DIAGNOSIS AND THERAPY
Christianah Aarinola Akinnawo1, Admire Dube1
1School of Pharmacy, University of the Western Cape, Bellville 7535, South Africa.
Advanced Therapeutics
|July 9, 2025
Summary
Metallic nanoparticles (MNPs) show promise for diagnosing and treating tuberculosis (TB). Further research is needed to translate these nanomedicine advancements into clinical applications for combating drug-resistant TB.
Area of Science:
- Nanomedicine
- Materials Science
- Infectious Diseases
Background:
- Tuberculosis (TB) presents a global health challenge due to non-adherence and rising drug-resistant strains.
- Novel diagnostic and therapeutic strategies are essential for effective TB control.
- Metallic nanoparticles (MNPs) offer potential for improved TB diagnosis and treatment.
Purpose of the Study:
- To review the properties and efficacy of therapeutically relevant MNPs for TB.
- To elucidate the antimycobacterial mechanisms of MNPs.
- To identify knowledge gaps for future research and clinical translation of TB nanomedicine.
Main Methods:
- Comprehensive literature analysis of existing studies on MNPs in TB nanomedicine.
- Evaluation of empirical findings on MNP properties and antimycobacterial activity.
- Identification of research gaps and future directions for clinical application.
Main Results:
- MNPs exhibit potential as sensor probes for TB diagnosis.
- Combination therapy using MNPs with antimycobacterial drugs shows promise for treatment.
- MNPs possess diverse antimycobacterial mechanisms.
Conclusions:
- Metallic nanoparticles are promising candidates for advanced TB diagnosis and treatment.
- Further pre-clinical and clinical research is crucial for the successful translation of MNP-based TB nanomedicine.
- Addressing knowledge gaps will facilitate the clinical application of these innovative technologies.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
207
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
01:28Pulmonary Tuberculosis V
243
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
243
01:29Pulmonary Tuberculosis I
331
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
331
01:31Pulmonary Tuberculosis III
451
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
451
01:28Pulmonary Tuberculosis II
379
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
379